Upon further testing, five factors were confirmed as true interacting partners; the remainder were excluded owing to nonspecific interactions or inability to bind E47/E12.
Heparin-like sulfated polysaccharides are potential drug candidates owing to their ability to interact with angiogenic factors and inhibit angiogenesis, tumor growth, and metastasis.
This shorter LEF-1 transcript (LEF-1-ΔL) is thought to be an inhibitory isoform [ 9, 10], owing to its ability to interact with cofactors that also bind LEF-1-FL, as well as compete for DNA binding sites, and thus has been termed "growth suppressing".
Besides having crucial roles in the viral life cycle, NP also functions as a key adapter molecule mediating the cross talk between virus and host cell processes, owing to its ability to interact with a wide variety of both viral as well as cellular factors.
Further, the E-value for Rab1 being quite high (3e−11; Supplementary Table S1), a criterion which can be used to test the quality of the prey sequence, it is quite possible that the Rab1-LmjMCA interaction is a false positive, simply owing to a small Rab1 interacting sequence potentially homologous to other protein domains.
While these tools offer a convenient and reliable method for such analyses, they are not amenable to large and/or ad hoc datasets owing to the inherent need to interact with a remote or local web site installation.
It is likely that TG2-R580A is unable to interact effectively with IκB, owing to its extended conformation.
The excellent performance of the mesoporous 5%Co-CeO2 catalyst should be owing to the small Co particles intimately interacted with CeO2 in the pore walls.
In contrast, the mutant M2, which did not interact with Osx owing to a partial deletion of the JmjC domain, showed weak inhibition of Osx-dependent activation even with the highest levels tested.
Finally, owing to its PDZ-binding domain (PBM), TAX interacts with hDLG, which binds to the adenomatous polyposis complex (APC) tumour suppressor and enforces G0/G1 cell cycle arrest.
